SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma
4 references·0 citing·16 second hop
Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma (2009)Cost Effectiveness of Rituximab Maintenan…Discounting Health Effects in Pharmacoeconomic Evaluations (2005)Discounting Health Effects in…Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis (2004)Does NICE have a cost‐effecti…A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK (2002)A comparative economic analys…The Costs and Cost-Effectiveness of Unrelated Donor Bone Marrow Transplantation for Chronic Phase Chronic Myelogenous Leukemia (1998)The Costs and Cost-Effectiven…The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)Key principles for the improved conduct of health technology assessments for resource allocation decisions (2008)International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)A Treatise of Human Nature (1739)11. Reasons and Persons (1986)Cost-Effectiveness in Health and Medicine (1996)Use of Global Visual Acuity Data in a Time Trade-off Approach to Calculate the Cost Utility of Cataract Surgery (2009)Discounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review (2015)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation (1997)The death of cost‐minimization analysis? (2001)Cost-effectiveness Analysis of Nivolumab for Treatment of Platinum-Resistant Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (2017)Cost-effectiveness of Nivolumab-Ipilimumab Combination Therapy for the Treatment of Advanced Non–Small Cell Lung Cancer (2021)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Markov Models in Medical Decision Making (1993)
this work references cited by second hop

References

  • 2004Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis710 cited
  • 2002A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK76 cited
  • 2005Discounting Health Effects in Pharmacoeconomic Evaluations66 cited
  • 1998The Costs and Cost-Effectiveness of Unrelated Donor Bone Marrow Transplantation for Chronic Phase Chronic Myelogenous Leukemia59 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work